Skip to main content
. 2018 Jun 11;18:37. doi: 10.1186/s12911-018-0606-x

Fig. 5.

Fig. 5

Antibody-mediated changes in the complex formation at the synapse in the free-diffusion model: The dynamic changes in the different complexes, such as CTLA-4/antibody, CTLA-4/B7 ligands and CD28/B7 ligands, at the synapse are simulated at 10 μM and 15 μM of antibodies, ipilimumab (a, c) and tremelimumab (b, d)